Clinical Trial Update: AccuLIF® PROSPECTIVE PATIENT OUTCOMES STUDY [NA]

View source ↗

Summary

Clinical trial update for the AccuLIF prospective patient outcomes study sponsored by Stryker Spine; the trial was terminated and results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Retrolisthesis
• Spondylolisthesis

Drugs mentioned

• AccuLIF

Snippet

Sponsor: Stryker Spine | Conditions: Degenerative Disc Disease, Spondylolisthesis, Grade 1 | NA | Status: TERMINATED | Results posted: 2018-04-24